Aizon

Revolutionizing Pharmaceutical Manufacturing with AI

Aizon is an intelligent GxP manufacturing platform purpose-built for pharmaceutical companies to improve yield, reduce deviations, and ensure product quality through real-time, practical Artificial Intelligence. The platform addresses the critical challenges facing pharma manufacturing: delivering quality drugs on time and on budget while maintaining strict regulatory compliance.

Comprehensive Suite of AI-Powered Solutions

Aizon offers four integrated products designed to transform pharmaceutical manufacturing operations:

• Aizon Execute: Revolutionizes manufacturing batch processing with AI-driven MBR conversion and recipe execution
• Aizon Unify: AI-powered contextualized intelligent lakehouse featuring digital batch review, real-time process monitoring, and batch comparison analytics
• Aizon Predict: Turbocharges predictive capabilities with yield optimization, deviation reduction, and advanced analytics
• Aizon Agentic Studio: Enables building dashboards and dynamic applications in natural language with no code required

Solving Critical Manufacturing Challenges

The platform empowers Quality Leaders with automated annual PQRs, faster batch releases, FDA audit readiness, streamlined CAPAs, and rapid deviation resolutions. Production Leaders benefit from increased customer transparency, yield optimization, interruption avoidance, capacity utilization improvement, COGS reduction, and improved operator adherence. TechOps Leaders gain tools to avoid over-maintaining assets, enable timely tech transfers, ensure continued process verification, achieve right-first-time processes, and perform better root cause analytics.

Rapid Implementation and Proven Results

Unlike generic solutions, Aizon delivers first results in weeks, not years. Through Aizon Consulting Services (ACS), the platform adapts to specific client needs with a structured 12-week implementation journey: integration framework and data contextualization (weeks 1-5), data exploration and hypothesis testing (weeks 4-6), solution validation with on-field CPP adjustments (weeks 5-11), and impact confirmation with cross-site industrialization (weeks 10-12).

Proven Success Across the Industry

Aizon has delivered measurable results for leading pharmaceutical companies and CDMOs globally, including Grifols and Curia, achieving major operational savings through multivariate root cause analysis, yield optimization with unified data, and reduced yield variability through automated batch comparisons. Built by pharma manufacturing professionals versed in technology, Aizon standardizes tools and processes while ensuring compliance, knowledge management, and cybersecurity across pharmaceutical manufacturing operations.